The molecular biology and therapeutic potential of Nrf2 in leukemiaAtefeh Khodakarami, Farhad Jadidi-Niaragh, Sara Adibfar et al.|Cancer Cell International|2022Cited by 46
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to CyclophosphamideAtefeh Khodakarami, Farhad Jadidi‐Niaragh, Armin Mahmoudsalehi Kheshti et al.|Cell Communication and Signaling|2023Cited by 16
The role of <scp>SF3B1</scp> and <scp>NOTCH1</scp> in the pathogenesis of leukemiaShiva Abolhasani, Farhad Jadidi‐Niaragh, Seyyed Sina Hejazian et al.|IUBMB Life|2022Cited by 7
IGF1R and HIF-1α Gene Silencing Inhibits Cancer Cell GrowthShiva Abolhasani, Farhad Jadidi‐Niaragh, Sepideh Javadi et al.|International Journal of Drug Research in Clinics|2023Cited by 1
Cover ImageShiva Abolhasani, Farhad Jadidi‐Niaragh, Seyyed Sina Hejazian et al.|IUBMB Life|2023Cited by 0